US FDA approves AstraZeneca's flu vaccine for self-administration
FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...
Nationwide Snack Recall Update As FDA Sets Highest Risk Level
The snacks now have a Class I risk level, meaning there is a "reasonable probability" they could cause "serious adverse ...
Health.com on MSN46m
Multiple Reports Have Found Lead in Cinnamon—Is It Still Safe to Eat?
Recent testing from Consumer Reports and the FDA has found elevated levels of lead in cinnamon products and spice mixes. You ...
STAT31m
FDA’s new head of device safety held senior role at company troubled by safety warnings
“Olympus’ continued failure to meet FDA requirements demonstrates a troubling disregard for patient safety,” said Jeffrey ...
FDA Approves Zevra's Miplyffa for Niemann-Pick Disease Type C -- 2nd Update
Zevra Therapeutics has won Food and Drug Administration approval of Miplyffa for Niemann-Pick disease type C, or NPC, making it the first drug cleared in the U.S. for the rare neurodegenerative ...
FDA Approves Nasal Spray Influenza Vaccine for Self- or Caregiver-Administration
Today, the U.S. Food and Drug Administration approved FluMist for self- or caregiver-administration. FluMist is approved for the prevention of influenza disease caused by influenza virus subtypes A ...
Dozens of Boar’s Head workers scrubbing plant infected by listeria — as company has no plans to reopen it
In an email to The Post this week, a Boar’s Head spokesperson said, “We do not currently have any plans to reopen this plant.
Zevra Therapeutics’ MIPLYFFA™ (arimoclomol) Receives U.S. FDA Approval as Treatment for Niemann-Pick Disease Type C
MIPLYFFA is the first FDA-approved treatment for Niemann-Pick disease type C (NPC), an ultra-rare and progressive neurodegenerative disease MIPLYFFA is indicated for use in combination with miglustat ...
FDA Approves First Treatment for Niemann-Pick Disease, Type C
Today, the U.S. Food and Drug Administration approved Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).
Baby Powder Recalled Nationwide Due to Possible Asbestos Contamination
The FDA announced a recall of Dynacare Baby Powder—here's what to know.